An observational study in Breast Cancer, sponsored by Centre Oscar Lambret. Completed at 4 sites in France. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-13.
Sponsored by Centre Oscar Lambret · Observational
The study aims to analyse and decode interviews of patient with breast cancer, and then established according a multidimensional profile specific to the population and to create a questionnaire tha will allow a practical and qualitative evaluation of the quality of life.
12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.
This study's enrollment of 171 is close to the median of 184 across 2,642 observational studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Centre Oscar Lambret is the lead sponsor of 127 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patient with breast cancer, diagnosed before aged 45, having a life partner
Inclusion Criteria:
Exclusion Criteria:
30 couples, interviewed within chemotherapy (6 to 8 months after diagnosis)
Behavioral: interview
30 couples, within herceptin treatment (the first year after diagnosis)
Behavioral: interview
30 couples, within hormonotherapy (between 2 and 7 years after diagnosis)
Behavioral: interview
30 couples, did not received hormonotherapy (1 year after diagnosis)
Behavioral: interview
30 couples, after end of treatments for patients who did received hormonotherapy (7 years after diagnosis)
Behavioral: interview
psychological, emotional, family and social parameters
quality of life at different time of medical follow up
interviews with couples at different time frame depending on which group they are in
Time frame: 6 months after diagnosis, 1 year after diagnosis, between 2 and 7 years after diagnosis, 7 years past diagnosis
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Oscar Lambret